L. Ruf

Prognostic factors for patients with acute myeloid leukaemia or high‐risk myelodysplastic syndromes undergoing myeloablative or non‐myeloablative allogeneic blood stem cell transplantation

U. Germing, G. Kobbe, R. Fenk, 2007, Hematological oncology.

Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma.

I. Bruns, U. Steidl, G. Kobbe, 2006, Experimental hematology.

Induction of tolerance after combined immunosuppression and -adsorption in two patients with acquired haemophilia after severe haemorrhages controlled by sequential administration of rFVIIa and FEIBA

W. Knoefel, R. Haas, R. Zotz, 2009, Thrombosis and Haemostasis.

Unrelated umbilical cord blood transplantation as salvage treatment for engraftment failure following autologous stem cell transplantation.

G. Kobbe, R. Fenk, R. Haas, 2008, Leukemia research.

Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.

I. Bruns, G. Kobbe, R. Fenk, 2007 .